News Image

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

Provided By PR Newswire

Last update: Mar 4, 2025

REDWOOD CITY, Calif., March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its fourth-quarter and full-year 2024 financial results.

Read more at prnewswire.com

GLOBUS MEDICAL INC - A

NYSE:GMED (10/17/2025, 8:16:56 PM)

After market: 59.58 0 (0%)

59.58

+1.01 (+1.72%)



Find more stocks in the Stock Screener

Follow ChartMill for more